We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMartin Currie Global Portfolio Trust Regulatory News (MNP)

Share Price Information for Martin Currie Global Portfolio Trust (MNP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 365.00
Bid: 365.00
Ask: 367.00
Change: -4.00 (-1.08%)
Spread: 2.00 (0.548%)
Open: 365.00
High: 366.00
Low: 363.00
Prev. Close: 369.00
MNP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Kepler Trust Intelligence: New research

15 Mar 2019 07:00

RNS Number : 9380S
Martin Currie Global Portfolio Tst
15 March 2019
 

Martin Currie Global Portfolio Trust: New research

15/03/19

· Martin Currie Global Portfolio Trust (MNP) aims to achieve long-term capital growth, in excess of the FTSE World index, whilst offering solid income for investors...

Read more

Martin Currie Global Portfolio Trust (MNP) aims to achieve long-term capital growth, in excess of the FTSE World index, whilst offering solid income for investors. Recently, there has been a change of lead-manager: having been at the helm of the trust for over 18 years, 2018 saw Tom Walker step down, and Zehrid Osmani take over, having joined Martin Currie in June. Although the objective remains the same, Zehrid brings with him a more concentrated approach, and an exceptional track record for generating alpha at BlackRock. This has led to a transition in the portfolio.

Having further concentrated the portfolio, it now has only 34 holdings, and with the top ten holdings making up over a third of the portfolio, the new manager is clearly willing to back his bets. MNP has an active share of 93.8% (versus the FTSE World), further showing the active and unconstrained approach. The investment strategy has been aligned with Martin Currie's distinctive Global Long-Term Unconstrained (GLTU) philosophy where the team looks for companies with high-quality growth characteristics, which they believe are undervalued. In particular, Zehrid is looking for companies who generate high returns on invested capital (ROIC), and the potential to sustain or further improve this. The portfolio has a slight bias toward large-cap equities and exposure is broadly diversified in geographical terms, although there is a significant weighting to the US - where over a third of the fund has revenue exposure. The largest sector weightings include industrials, technology and consumer goods, both on an absolute and relative basis.

With the arrival of Zehrid there is evidence to believe that the trust's fortunes have changed as it has risen up the sector rankings, following a period of lesser performance. Since he joined, the trust has delivered NAV returns of 2.8%, almost double the benchmark (1.5%) and over 5% greater than the global closed-ended (-2.4%) and open-ended (-0.1%) peer groups.

Click here to read the full report

 

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful.

Important information

Martin Currie Global Portfolio Trust is a client of Kepler Trust Intelligence. This material should be considered a marketing communication, and is not independent research.

Kepler Partners is not authorised to make recommendations to Retail Clients. This report is based on factual information only, and is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

This report has been issued by Kepler Partners LLP solely for information purposes only and the views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment. If you are unclear about any of the information on this website or its suitability for you, please contact your financial or tax adviser, or an independent financial or tax adviser before making any investment or financial decisions.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. Persons who access this information are required to inform themselves and to comply with any such restrictions. In particular, this website is exclusively for non-US Persons. The information in this website is not for distribution to and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States of America to or for the benefit of US Persons.

This is a marketing document, should be considered non-independent research and is subject to the rules in COBS 12.3 relating to such research. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research.

No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not to be taken as advice to take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's conflict of interest policy is available on request.

Past performance is not necessarily a guide to the future. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that Independent financial advice should be taken before entering into any financial transaction.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is a limited liability partnership registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority.

 

 

About this service

Kepler Trust Intelligence for private investors is not just another news and research website. Our aim is to create a library of high quality investment strategy research, fund analysis and useful guides for private investors, all written in-house by experienced analysts on the investment companies team at Kepler Partners.

We are focused entirely on investment trusts, however we believe that it helps to understand them better if they are placed on a level playing field with OEICs, so you will see comparisons between the two in these pages often.

 

Our content falls into three categories;

Investment strategy articles are designed to highlight opportunities and developments which are of interest to investment trust investors, positive or negative.

Fund research focuses on individual trusts, examining them in detail to create a snapshot picture which you can use to decide whether or not you want to invest in them.

Educational output is split into simple guides, designed to help beginners understand how investment trusts work, and more complex guides to sectors, regions and strategies which may be of interest to investors.

We do not produce massive amounts of research. Our focus is on quality, not quantity, so we are unlikely to publish more than four or five articles in a given week. For this reason we recommend that you join our mailing list, and we'll send you an email once a week alerting you to what's new on the site. We won't sell your details, and we won't spam you with useless updates.

 

How are we funded?

Kepler Trust Intelligence is funded entirely by the providers of investment trusts, and is made available freely to any person (professional or private individual) who wants to access it. We clearly disclose all of our relationships, but our research is either paid for directly by specific trusts and their boards, or more generally by the larger asset management groups who pay to have adverts and advertorial. As a result, all of our research should be considered "non-independent" and readers should consider it as marketing.

All of our content is freely available to anyone. We run two versions of the site - one for professionals and one for private investors. The professional site requires readers to volunteer the name of the company they work for and the city / region - so that from a compliance perspective we can be satisfied that all readers really are a professional.

 

We provide information, not advice

While we hope that you find the research we publish useful, and we believe it will help you to make a more informed decision, but we must of course stress that none of the research published here constitutes a recommendation, or advice, and you should not think that - just because we've published a report on a trust - we believe that trust is a 'buy'. Please read our terms and conditions.

 

If you want to manage your own investments we hope that this website is a useful source of information which helps you to do that, however if you are in any doubt, you should speak to a financial adviser.

 

Pascal Dowling

 

Kepler Partners

 

 

 

END

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEAKDLFASNEFF
Date   Source Headline
19th Apr 20244:52 pmRNSTransaction in Own Shares
19th Apr 20248:48 amRNSNet Asset Value(s)
18th Apr 20244:47 pmRNSTransaction in Own Shares
18th Apr 20248:55 amRNSNet Asset Value(s)
17th Apr 20244:46 pmRNSTransaction in Own Shares
17th Apr 20249:04 amRNSNet Asset Value(s)
16th Apr 20244:44 pmRNSTransaction in Own Shares
16th Apr 20248:37 amRNSNet Asset Value(s)
15th Apr 20244:50 pmRNSTransaction in Own Shares
15th Apr 20249:03 amRNSNet Asset Value(s)
12th Apr 20244:52 pmRNSTransaction in Own Shares
12th Apr 20249:06 amRNSNet Asset Value(s)
11th Apr 20244:51 pmRNSTransaction in Own Shares
11th Apr 20248:43 amRNSNet Asset Value(s)
10th Apr 20244:46 pmRNSTransaction in Own Shares
10th Apr 20248:52 amRNSNet Asset Value(s)
9th Apr 20244:51 pmRNSTransaction in Own Shares
9th Apr 20248:52 amRNSNet Asset Value(s)
8th Apr 20244:55 pmRNSTransaction in Own Shares
8th Apr 20248:48 amRNSNet Asset Value(s)
5th Apr 20248:47 amRNSNet Asset Value(s)
4th Apr 20244:50 pmRNSTransaction in Own Shares
4th Apr 20248:44 amRNSNet Asset Value(s)
3rd Apr 20244:48 pmRNSTransaction in Own Shares
3rd Apr 20249:16 amRNSNet Asset Value(s)
2nd Apr 20244:50 pmRNSTransaction in Own Shares
2nd Apr 20247:59 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSNet Asset Value(s)
28th Mar 20244:54 pmRNSTransaction in Own Shares
28th Mar 20249:12 amRNSNet Asset Value(s)
27th Mar 20244:47 pmRNSTransaction in Own Shares
27th Mar 202410:24 amRNSDividend Declaration
27th Mar 20249:03 amRNSNet Asset Value(s)
26th Mar 20244:52 pmRNSTransaction in Own Shares
26th Mar 20249:10 amRNSNet Asset Value(s)
25th Mar 20244:53 pmRNSTransaction in Own Shares
25th Mar 20249:01 amRNSNet Asset Value(s)
22nd Mar 20244:54 pmRNSTransaction in Own Shares
22nd Mar 20248:23 amRNSNet Asset Value(s)
21st Mar 20244:51 pmRNSTransaction in Own Shares
21st Mar 20248:55 amRNSNet Asset Value(s)
20th Mar 20244:54 pmRNSTransaction in Own Shares
20th Mar 20248:53 amRNSNet Asset Value(s)
19th Mar 20244:49 pmRNSTransaction in Own Shares
19th Mar 20248:52 amRNSNet Asset Value(s)
18th Mar 20244:48 pmRNSTransaction in Own Shares
18th Mar 20248:42 amRNSNet Asset Value(s)
15th Mar 20244:55 pmRNSTransaction in Own Shares
15th Mar 20249:37 amRNSMAR Article 19 Paragraph 11
15th Mar 20248:53 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.